⌘K

BeiGene, Ltd. (BGNE)

$205.47 -0.65% $-1.35 Healthcare

BeiGene, Ltd., a biotechnology company, focuses on discovering, developing, manufacturing, and commercializing various medicines worldwide. Its products include BRUKINSA to treat relapsed/refractory (R/R) mantle cell lymphoma; Tislelizumab to treat R/R classical Hodgkin's lymphoma; REVLIMID to treat multiple myeloma; VIDAZA to treat myelodysplastic syndromes, chronic myelomonocyte leukemia, and acute myeloid leukemia; XGEVA to treat giant cell tumor of bone; BLINCYTO to treat acute lymphoblastic leukemia; KYPROLIS to treat R/R multiple myeloma; SYLVANT to treat idiopathic multicentric castleman disease; QARZIBA to treat neuroblastoma; Pamiparib for the treatment of various solid tumors; and Pobevcy to treat metastatic colorectal cancer, liver cancer, and non-small cell lung cancer (NSCLC). The company's clinical stage drug candidates comprise Zanubrutinib, a BTK inhibitor to treat lymphomas; Tislelizumab, an anti-PD-1 antibody to treat solid and hematological cancers; Lifirafenib and BGB-3245 to treat melanoma, NSCLC, and endometrial cancer; and Sitravatinib, a multi-kinase inhibitor to treat NSCLC, melanoma, and other solid tumors. Its clinical stage drug candidates also include BGB-A333, a PD-L1 inhibitor to treat various solid tumors; Ociperlimab, a TIGIT inhibitor to treat various solid tumors; BGB-11417, a small molecule Bcl-2 inhibitor to treat mature B-cell malignancies; BGB-A445, an OX40 agonist antibody to treat solid tumors; Zanidatamab, a bispecific HER2 inhibitor to treat breast and gastric cancer; BGB-A425, a T-cell immunoglobulin and mucin-domain containing-3 inhibitor to treat various solid tumors; and BGB-15025, a small molecule inhibitor of HPK1. The company has strategic collaborations with Shoreline Biosciences, Inc., Amgen Inc., Novartis AG, and Bristol Myers Squibb company. BeiGene, Ltd. was incorporated in 2010 and is headquartered in Cambridge, Massachusetts.

Market cap

$22.99B

CEO

Mr. John V. Oyler

Full time employees

9,000.00

Headquarters

Cambridge, MA

IPO Date

Feb 03, 2016

Price-to-earnings (PE) Ratio

-40.69

Earnings-per-share (EPS)

$-5.05

Cash ratio (TTM)

1.35

Current ratio (TTM)

1.98

Net profit margin (TTM)

-16.91%

PE ratio (TTM)

-41.35

PEG ratio (TTM)

1.52

Price-to-book ratio (TTM)

6.43

Price-to-sales ratio (TTM)

7.37

Quick ratio (TTM)

1.75

Return on assets (TTM)

-9.17%

Return on equity (TTM)

-14.93%

Similar stocks (12)

Incyte Corporation

INCY

$83.38 1.26% $1.04

Uptrend

Vaxcyte, Inc.

PCVX

$106.67 3.87% $3.97

Neutral

BioMarin Pharmaceutical Inc.

BMRN

$67.07 0.19% $0.13

Downtrend

Legend Biotech Corporation

LEGN

$40.03 -2.25% $-0.92

Downtrend

Blueprint Medicines Corporation

BPMC

$100.83 -0.55% $-0.56

Neutral

Ionis Pharmaceuticals, Inc.

IONS

$39.19 1.90% $0.73

Downtrend

Krystal Biotech, Inc.

KRYS

$199.61 7.64% $14.16

Uptrend

Immunovant, Inc.

IMVT

$30.65 2.41% $0.72

Downtrend

Apellis Pharmaceuticals, Inc.

APLS

$29.98 4.31% $1.24

Downtrend

Arrowhead Pharmaceuticals, Inc.

ARWR

$21.89 2.34% $0.50

Downtrend

Akero Therapeutics, Inc.

AKRO

$34.45 -1.20% $-0.42

Uptrend

Travere Therapeutics, Inc.

TVTX

$19.85 12.40% $2.19

Uptrend

ETF Exposure (22)

Loncar Cancer Immunotherapy ETF

CNCR

3.19%

$15.72 -0.51% $-0.08

Neutral

First Trust NYSE Arca Biotechnology Index Fund

FBT

2.79%

$178.69 0.33% $0.59

Uptrend

ERShares Entrepreneur ETF

ENTR

2.07%

$15.31 -1.03% $-0.16

Uptrend

Global X Aging Population ETF

AGNG

1.62%

$32.19 -0.03% $-0.01

Neutral

iShares Biotechnology ETF

IBB

1.60817%

$148.85 0.56% $0.83

Uptrend

BlackRock Future Health ETF

BMED

1.36896%

$26.49 0.61% $0.16

Uptrend

Invesco Nasdaq Biotechnology ETF

IBBQ

0.884%

$24.47 0.53% $0.13

Uptrend

Vanguard Capital Opportunity Fund

VHCAX

0.63%

$211.28 0.93% $1.95

Uptrend

Vanguard Capital Opportunity Fund Investor Shares

VHCOX

0.63%

$91.50 0.93% $0.84

Uptrend

Invesco NASDAQ Next Gen 100 ETF

QQQJ

0.56%

$31.75 1.34% $0.42

Uptrend

Invesco ESG NASDAQ Next Gen 100 ETF

QQJG

0.515%

$24.40 0.45% $0.11

Uptrend

Vanguard PRIMECAP Fund Admiral Shares

VPMAX

0.41%

$184.07 1.03% $1.87

Uptrend

Vanguard PrimeCap Fund

VPMCX

0.41%

$177.62 1.03% $1.81

Uptrend

ProShares Ultra Nasdaq Biotechnology

BIB

0.2593258850482216%

$66.86 1.33% $0.88

Uptrend

Xtrackers Emerging Markets Carbon Reduction and Climate Improvers ETF

EMCR

0.06099854%

$31.76 -2.78% $-0.91

Uptrend

Dimensional Emerging Markets Sustainability Core 1 ETF

DFSE

0.049956589999999995%

$34.51 -2.68% $-0.95

Uptrend

T. Rowe Price US Equity Research ETF

TSPA

0.046487%

$37.68 0.35% $0.13

Uptrend

Fidelity Nasdaq Composite Index ETF

ONEQ

0.04%

$76.04 0.11% $0.08

Uptrend

Dimensional Emerging Core Equity Market ETF

DFAE

0.01464739%

$26.60 -2.42% $-0.66

Uptrend

Dimensional Emerging Markets Core Equity 2 ETF

DFEM

0.01341355%

$27.30 -2.40% $-0.67

Uptrend

WisdomTree Emerging Markets Efficient Core Fund

NTSE

0.001623%

$30.59 -2.47% $-0.77

Neutral

VanEck Biotech ETF

BBH

$174.89 0.42% $0.74

Neutral

Similar stocks (12)

Incyte Corporation

INCY

$83.38 1.26% $1.04

Uptrend

Vaxcyte, Inc.

PCVX

$106.67 3.87% $3.97

Neutral

BioMarin Pharmaceutical Inc.

BMRN

$67.07 0.19% $0.13

Downtrend

Legend Biotech Corporation

LEGN

$40.03 -2.25% $-0.92

Downtrend

Blueprint Medicines Corporation

BPMC

$100.83 -0.55% $-0.56

Neutral

Ionis Pharmaceuticals, Inc.

IONS

$39.19 1.90% $0.73

Downtrend

Krystal Biotech, Inc.

KRYS

$199.61 7.64% $14.16

Uptrend

Immunovant, Inc.

IMVT

$30.65 2.41% $0.72

Downtrend

Apellis Pharmaceuticals, Inc.

APLS

$29.98 4.31% $1.24

Downtrend

Arrowhead Pharmaceuticals, Inc.

ARWR

$21.89 2.34% $0.50

Downtrend

Akero Therapeutics, Inc.

AKRO

$34.45 -1.20% $-0.42

Uptrend

Travere Therapeutics, Inc.

TVTX

$19.85 12.40% $2.19

Uptrend

ETF Exposure (22)

Loncar Cancer Immunotherapy ETF

CNCR

3.19%

$15.72 -0.51% $-0.08

Neutral

First Trust NYSE Arca Biotechnology Index Fund

FBT

2.79%

$178.69 0.33% $0.59

Uptrend

ERShares Entrepreneur ETF

ENTR

2.07%

$15.31 -1.03% $-0.16

Uptrend

Global X Aging Population ETF

AGNG

1.62%

$32.19 -0.03% $-0.01

Neutral

iShares Biotechnology ETF

IBB

1.60817%

$148.85 0.56% $0.83

Uptrend

BlackRock Future Health ETF

BMED

1.36896%

$26.49 0.61% $0.16

Uptrend

Invesco Nasdaq Biotechnology ETF

IBBQ

0.884%

$24.47 0.53% $0.13

Uptrend

Vanguard Capital Opportunity Fund

VHCAX

0.63%

$211.28 0.93% $1.95

Uptrend

Vanguard Capital Opportunity Fund Investor Shares

VHCOX

0.63%

$91.50 0.93% $0.84

Uptrend

Invesco NASDAQ Next Gen 100 ETF

QQQJ

0.56%

$31.75 1.34% $0.42

Uptrend

Invesco ESG NASDAQ Next Gen 100 ETF

QQJG

0.515%

$24.40 0.45% $0.11

Uptrend

Vanguard PRIMECAP Fund Admiral Shares

VPMAX

0.41%

$184.07 1.03% $1.87

Uptrend

Vanguard PrimeCap Fund

VPMCX

0.41%

$177.62 1.03% $1.81

Uptrend

ProShares Ultra Nasdaq Biotechnology

BIB

0.2593258850482216%

$66.86 1.33% $0.88

Uptrend

Xtrackers Emerging Markets Carbon Reduction and Climate Improvers ETF

EMCR

0.06099854%

$31.76 -2.78% $-0.91

Uptrend

Dimensional Emerging Markets Sustainability Core 1 ETF

DFSE

0.049956589999999995%

$34.51 -2.68% $-0.95

Uptrend

T. Rowe Price US Equity Research ETF

TSPA

0.046487%

$37.68 0.35% $0.13

Uptrend

Fidelity Nasdaq Composite Index ETF

ONEQ

0.04%

$76.04 0.11% $0.08

Uptrend

Dimensional Emerging Core Equity Market ETF

DFAE

0.01464739%

$26.60 -2.42% $-0.66

Uptrend

Dimensional Emerging Markets Core Equity 2 ETF

DFEM

0.01341355%

$27.30 -2.40% $-0.67

Uptrend

WisdomTree Emerging Markets Efficient Core Fund

NTSE

0.001623%

$30.59 -2.47% $-0.77

Neutral

VanEck Biotech ETF

BBH

$174.89 0.42% $0.74

Neutral